Zhongshu Kuang
180 Fenglin Road
Xuhui, 200032, China
Xuhui, 200032, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Glucocorticoid-mediated suppression of the CCL2-CCR2 axis drives monocyte dysfunction in severe pneumonia among immunocompromised hosts.
Journal: Respiratory research
Published: September 18, 2025
Large-scale proteomic profiling identifies distinct inflammatory phenotypes in acute respiratory distress syndrome: a multicentre, prospective cohort study.
Journal: The European respiratory journal
Published: May 03, 2025
Myeloid-Driven Immune Suppression Subverts Neutralizing Antibodies and T Cell Immunity in Severe COVID-19.
Journal: Journal of medical virology
Published: November 28, 2024
Impact of metagenomics next-generation sequencing on etiological diagnosis and early outcomes in sepsis.
Journal: Journal of translational medicine
Published: November 12, 2024
Uncovering host response in adults with severe community-acquired pneumonia: a proteomics and metabolomics perspective study.
Journal: World journal of emergency medicine
Published: October 16, 2024
A follow-up study on the recovery and reinfection of Omicron COVID-19 patients in Shanghai, China.
Journal: Emerging microbes & infections
Published: September 21, 2023
GLOBAL SIGNATURES OF THE MICROBIOME AND METABOLOME DURING HOSPITALIZATION OF SEPTIC PATIENTS.
Journal: Shock (Augusta, Ga.)
Published: March 23, 2023
Reduced clinical severity during 2022 Shanghai Spring epidemic of SARS-CoV-2 omicron BA.2 variant infection-an integrated account of virus pathogenicity and vaccination effectiveness.
Journal: National science review
Published: February 28, 2023
Gpr174 Knockout Alleviates DSS-Induced Colitis via Regulating the Immune Function of Dendritic Cells.
Journal: Frontiers in immunology
Published: December 22, 2021
The pathogens of secondary infection in septic patients share a similar genotype to those that predominate in the gut.
Journal: Critical care (London, England)
Published: November 24, 2021
GPR174 mRNA Acts as a Novel Prognostic Biomarker for Patients With Sepsis via Regulating the Inflammatory Response.
Journal: Frontiers in immunology
Published: October 04, 2021
Last Updated: 09/26/2026